Photo from academic.microsoft.com
A 65-year-old woman with κ light chain myeloma in partial remission experienced clinically significant toxicity related to her chemotherapy. When chemotherapy was discontinued her serum free κ light chain concentration… Click to show full abstract
A 65-year-old woman with κ light chain myeloma in partial remission experienced clinically significant toxicity related to her chemotherapy. When chemotherapy was discontinued her serum free κ light chain concentration increased, resulting in a free κ/free λ ratio greater than 27.75 (reference interval 0.58–2.24). A new treatment was initiated, and subsequent testing documented a reduction in her free κ/free λ ratio. A …
Keywords:
patient refractory;
refractory multiple;
monoclonal band;
new monoclonal;
band patient;
multiple myeloma
Journal Title: Clinical chemistry
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical chemistry
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!